Edwards Lifesciences Corporation

$82.97+0.99%(+$0.81)
TickerSpark Score
74/100
Solid
52
Valuation
90
Profitability
45
Growth
84
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EW research report →

52-Week Range68% of range
Low $72.30
Current $82.97
High $87.89

Companywww.edwards.com

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy.

CEO
Bernard J. Zovighian
IPO
2000
Employees
15,800
HQ
Irvine, CA, US

Price Chart

+6.60% · this period
$87.18$79.92$72.65May 20Nov 18May 20

Valuation

Market Cap
$47.77B
P/E
43.98
P/S
7.58
P/B
4.65
EV/EBITDA
32.06
Div Yield
0.00%

Profitability

Gross Margin
78.01%
Op Margin
27.62%
Net Margin
17.34%
ROE
10.55%
ROIC
12.06%

Growth & Income

Revenue
$6.07B · 11.55%
Net Income
$1.07B · -74.28%
EPS
$1.84 · -73.64%
Op Income
$1.64B
FCF YoY
360.50%

Performance & Tape

52W High
$87.89
52W Low
$72.30
50D MA
$81.53
200D MA
$81.26
Beta
0.87
Avg Volume
4.95M

Get TickerSpark's AI analysis on EW

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
May 18, 26Lippis Daniel J.other620
May 18, 26Lippis Daniel J.sell620
May 18, 26Lippis Daniel J.other620
May 15, 26BOBO DONALD E JRsell8,000
May 15, 26BOBO DONALD E JRsell9,968
May 11, 26Zovighian Bernard Jother47,207
May 11, 26Zovighian Bernard Jother26,198
May 12, 26Zovighian Bernard Jother26,640
May 12, 26Zovighian Bernard Jother26,640
May 12, 26Zovighian Bernard Jsell845

Our EW Coverage

We haven't published any research on EW yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate EW Report →

Similar Companies